For following the competition: what moved in each program, several studies read as one move.
- nirogacestat
- Anti-CD39 Antibody/TGF-beta RII Ectodomain Fusion Protein ES014
- Beta-catenin Antagonist ST316
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Desmoid Tumors to watchlistEvery Monday by email · turn it off any timePro · free during the beta